Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 8, 2026
May 8, 2026
ffcc278f-6d9f-40a2-8bf5-46599aad2a4a
Related Documents
Statistical Approaches to Establishing Bioequivalence
Guidance DocumentMay 29, 2026Center for Drug Evaluation and Research
Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
Guidance DocumentMarch 17, 2026Center for Drug Evaluation and Research
Pulmonary Tuberculosis: Developing Drugs for Treatment: Guidance for Industry
Guidance DocumentMay 8, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.